uvstocks.io

Today’s CSR movers

ETR 4.0 ▲ 1.5

SO 3.0 ▲ 1.0

NTAP 3.6 ▲ 0.5

PWR 4.6 ▲ 0.5

SNPS 4.6 ▲ 0.5

APA 3.1 ▲ 0.1

ITW 2.7 ▲ 0.1

CF 2.9 ▼ 0.1

VMC 3.7 ▼ 0.1

COO 3.6 ▼ 0.1

Health Care · NYSE NYSE · PFE

Pfizer

$27.72 +$0.07 +0.25% CLOSE 09.11.26 AFTER HOURS $27.73

Convergence score

3.1 / 5.0 NEUTRAL

+0.0 vs last report

Overall valuation

Undervalued

Aggregated across multiple horizons

Consensus target (12mo)

$28.62 +3.3%

Range $25.00 — $35.75

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 09.11.26

UV Convergence Score

REPORT 09.11.26

3.1

/ 5.0

NEUTRAL

Consensus signal A

3.0

Consensus signal B

3.0

Consensus signal D

3.0

Analyst average

3.5

Multi-signal aggregate How CSR works →

Day Range

$27.42 – $27.85

52W Range

$23.58 – $29.21

Volume

25.5M

Avg Vol

42.0M

Mkt Cap

$157.99B

P/E

36.47

EPS (TTM)

$0.76

Div Yield

6.22%

Beta

0.30

Today's convergence

Convergence score sits at 3.1 with overall valuation reading as undervalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Undervalued

CSR direction

NEUTRAL

Last close

$27.72

Sector

Health Care

Valuation

Three horizons

UPDATED 09.11.26

Short term

0–3 MO

No target —

Medium term

3–12 MO

$28+2.4% Hold

Long term

12–36 MO

$37.20+34.2% Undervalued

Open valuation →

Analysts

Coverage & consensus

5 PANELS

Mean target (12mo)

$28.62 +3.3%

RANGE $25.00 — $35.75

Analyst consensus

Consensus rating Hold

Blended score 3.3 / 5

Analysts tracked 131

Open analysts →

Financials

Key metrics

LATEST

P/E

36.47

EPS (TTM)

$0.76

Mkt Cap

$157.99B

Div Yield

6.22%

Beta

0.30

52W Range

$23.58 – $29.21

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26

Short term

0–3 MO

—

Consensus target

No target available

Medium term

3–12 MO

Hold

Consensus target

$28 +2.4%

RANGE $25 – $35

$25NOW $27.72$35

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Undervalued

Consensus target

$37.20 +34.2%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 36.47	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $12.49B	PB Ratio: -	PS Ratio: -	Dividend: $0.43

Analyst coverage

Blended analyst consensus & targets.

5 PANELS · UPDATED 09.11.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Hold 3.3 5 131

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $25.00 $28.62 $28.00 $35.75 +3.3%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 3 12 30 3 1

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current — — —

1 Mo Ago — — —

2 Mo Ago — — —

3 Mo Ago — — —

Most recent analyst action LATEST DESK ACTION

Date

9/10/2026

Firm

HSBC

Action

Boost Target

Rating

Hold

Target

$30.00

Full financial snapshot.

UPDATED 09.11.26

Quote snapshot 15 FIELDS

Prev Close

$27.65

Open

$27.80

Day Low

$27.42

Day High

$27.85

Bid

$27.61

Ask

$27.72

52W Low

$23.58

52W High

$29.21

50D Avg

$26.19

200D Avg

$26.21

Volume

25.5M

Avg Vol

42.0M

10D Avg Vol

32.6M

52W Change

15.84%

S&P 52W Change

15.30%

Valuation ratios 10 FIELDS

P/E (TTM)

36.47

P/E (Fwd)

9.57

PEG (Fwd)

2.72

P/S

2.48

P/B

1.85

Book Value

$14.95

EV/Revenue

3.29

EV/EBITDA

8.26

Mkt Cap

157.99B

Enterprise Val

209.67B

Profitability & returns 6 FIELDS

Profit Margin

6.80%

Gross Margin

74.72%

Operating Margin

27.88%

EBITDA Margin

39.85%

Return on Assets

5.78%

Return on Equity

5.01%

Growth 3 FIELDS

Revenue Growth (YoY)

2.60%

Earnings Growth (YoY)

—

Earnings Growth (Q)

—

Balance sheet & cash flow 11 FIELDS

Total Revenue

63.7B

EBITDA

25.38B

Total Cash

11.7B

Total Debt

63.48B

Cash / Share

$2.05

Revenue / Share

$11.19

Free Cash Flow

12.49B

Operating CF

13.4B

Debt / Equity

74.25

Current Ratio

1.27

Quick Ratio

0.85

Dividend 5 FIELDS

Fwd Dividend

1.72 (6.22%)

Dividend Yield

6.22%

Payout Ratio

226.32%

5Y Avg Yield

5.20%

Ex-Div Date

2026-07-24

Share statistics 7 FIELDS

Shares Out

5.7B

Float

5.69B

Shares Short

151.54M

% Short of Float

2.66%

Short Ratio

3.91

% Held Insiders

0.10%

% Held Institutions

69.12%

Calendar & events 5 FIELDS

Next Earnings

2026-11-03

Fiscal Year End

2025-12-31

Most Recent Qtr

2026-06-28

Last Split

1054:1000

Split Date

2020-11-17

Company 2 FIELDS

Industry

Drug Manufacturers - General

Employees

75,000